• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  cyclosporine 2% ophthalmic ointment
Date Designated:  08/01/1991
Orphan Designation:  Treatment of patients at high risk of graft rejection following penetrating keratoplasty
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Allergan, Inc.
2525 Dupont Drive
P. O. Box 19534
Irvine, California 92612
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.